MAPT and tauopathy: Similarly, the pT181 tau epitope becomes pathologically modified earlier in the disease than both the AT8 and PHF1 sites which could explain why our previous Qβ-pT181 vaccine demonstrated the highest efficacy in the same animal model of tauopathy using the same vaccine dosing schedule.